Item Type | Name |
Academic Article
|
Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy.
|
Academic Article
|
Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy.
|
Academic Article
|
A multidisciplinary protocol for planned skin-preserving delayed breast reconstruction for patients with locally advanced breast cancer requiring postmastectomy radiation therapy: 3-year follow-up.
|
Academic Article
|
Determining the optimal approach to breast reconstruction after partial mastectomy.
|
Academic Article
|
Practical guidelines for repair of partial mastectomy defects using the breast reduction technique in patients undergoing breast conservation therapy.
|
Academic Article
|
Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast.
|
Academic Article
|
Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapy.
|
Academic Article
|
Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction.
|
Academic Article
|
Advances and surgical decision-making for breast reconstruction.
|
Concept
|
Recurrence
|
Concept
|
Neoplasm Recurrence, Local
|
Academic Article
|
Clinical course of breast cancer patients with isolated sternal and full-thickness chest wall recurrences treated with and without radical surgery.
|
Academic Article
|
Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancer.
|
Academic Article
|
Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases.
|
Academic Article
|
Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation.
|
Academic Article
|
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.
|
Academic Article
|
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
|
Academic Article
|
T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
|
Academic Article
|
Repeat breast-conserving surgery for in-breast local breast carcinoma recurrence: the potential role of partial breast irradiation.
|
Academic Article
|
Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
|
Academic Article
|
Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy.
|
Academic Article
|
Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma.
|
Academic Article
|
Paget's disease of the breast: there is a role for breast-conserving therapy.
|
Academic Article
|
Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence.
|
Academic Article
|
Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
|
Academic Article
|
Breast cancer in the asian Indian population of the United States: a call for screening and education.
|
Academic Article
|
Biology, treatment, and outcome in very young and older women with DCIS.
|
Academic Article
|
Tumor bed control with balloon-based accelerated partial breast irradiation: incidence of true recurrences versus elsewhere failures in the American Society of Breast Surgery MammoSite(?) Registry Trial.
|
Academic Article
|
Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer.
|
Academic Article
|
Ductal carcinoma-in-situ: long-term results of breast-conserving therapy.
|
Academic Article
|
Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy.
|
Academic Article
|
Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma.
|
Academic Article
|
Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy.
|
Academic Article
|
Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
|
Academic Article
|
Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: implications for post-mastectomy radiation therapy.
|
Academic Article
|
Accelerated partial breast irradiation after conservative surgery for breast cancer.
|
Academic Article
|
The biologic rationale for and emerging role of accelerated partial breast irradiation for breast cancer.
|
Academic Article
|
Breast conservation after neoadjuvant chemotherapy.
|
Academic Article
|
Advances in breast conservation therapy.
|
Academic Article
|
Improving local control with breast-conserving therapy: a 27-year single-institution experience.
|
Academic Article
|
The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy.
|
Academic Article
|
Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI).
|
Academic Article
|
Outcome after ipsilateral breast tumor recurrence in patients who receive accelerated partial breast irradiation.
|
Academic Article
|
Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass.
|
Academic Article
|
Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.
|
Academic Article
|
Presentation, treatment, and outcome of local recurrence afterskin-sparing mastectomy and immediate breast reconstruction.
|
Academic Article
|
Local recurrence and survival among black women with early-stage breast cancer treated with breast-conservation therapy or mastectomy.
|
Academic Article
|
Presentation, management and outcome of axillary recurrence from breast cancer.
|
Academic Article
|
Chest wall recurrence after mastectomy does not always portend a dismal outcome.
|
Academic Article
|
Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.
|
Academic Article
|
Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation.
|
Academic Article
|
Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast.
|
Academic Article
|
Sentinel lymph node surgery in locally recurrent breast cancer.
|
Academic Article
|
Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial.
|
Academic Article
|
Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer.
|
Academic Article
|
Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients.
|
Academic Article
|
Update on DCIS outcomes from the American Society of Breast Surgeons accelerated partial breast irradiation registry trial.
|
Academic Article
|
Intraoperative radiotherapy for early breast cancer.
|
Academic Article
|
Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.
|
Academic Article
|
Ductal carcinoma-in-situ of the breast with subsequent distant metastasis and death.
|
Academic Article
|
Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
|
Academic Article
|
Local control, toxicity, and cosmesis in women >70 years enrolled in the American Society of Breast Surgeons accelerated partial breast irradiation registry trial.
|
Academic Article
|
Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy.
|
Academic Article
|
Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy.
|
Academic Article
|
Outcomes and predictive factors for salvage therapy after local--regional recurrence following neoadjuvant chemotherapy and breast conserving therapy.
|
Academic Article
|
Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?
|
Academic Article
|
Breast-conservation therapy in early-stage breast cancer patients with a positive family history.
|
Academic Article
|
Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
|
Academic Article
|
Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System registry trial.
|
Academic Article
|
Treatment and outcome of patients with intracystic papillary carcinoma of the breast.
|
Academic Article
|
Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy.
|
Academic Article
|
Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
|
Academic Article
|
Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy.
|
Academic Article
|
Minimally invasive operation for breast cancer.
|
Academic Article
|
Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review.
|
Academic Article
|
RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.
|
Academic Article
|
Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I-III Triple-Negative Breast Cancer.
|
Academic Article
|
Ductal Carcinoma In Situ: Treatment Update and Current Trends.
|
Academic Article
|
Circulating Tumor Cells and Recurrence After Primary Systemic Therapy in Stage III Inflammatory Breast Cancer.
|
Academic Article
|
Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence.
|
Academic Article
|
Lipofilling of the Breast Does Not Increase the Risk of Recurrence of Breast Cancer: A Matched Controlled Study.
|
Academic Article
|
Exeresis and brachytherapy as salvage treatment for local recurrence after conservative treatment for breast cancer
|
Academic Article
|
Breast preservation in patients with local recurrence after breast-conserving therapy
|
Academic Article
|
Biological markers in DCIS and risk of breast recurrence
|
Academic Article
|
Predictors of systemic recurrence and impact of local failure among early stage breast cancer patients treated with breast conserving therapy
|
Academic Article
|
2-23 Salvage Treatment for Local or Local-Regional Recurrence After Initial Breast Conservation Treatment With Radiation for Ductal Carcinoma In Situ
|
Academic Article
|
Breast conserving surgery and locoregional control after neoadjuvant chemotherapy.
|
Academic Article
|
Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy.
|
Academic Article
|
NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence.
|
Academic Article
|
Optimizing Breast Cancer Adjuvant Radiation and Integration of Breast and Reconstructive Surgery.
|
Academic Article
|
A 10-Year Experience with Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and Reconstruction.
|
Academic Article
|
Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery.
|
Academic Article
|
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.
|
Academic Article
|
OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients.
|
Academic Article
|
Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement.
|
Academic Article
|
Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial.
|
Academic Article
|
The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer.
|
Academic Article
|
Same-Day Breast Cancer Surgery and TARGIT-IORT: Better than Selective Omission of Radiotherapy?
|
Academic Article
|
Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy.
|
Academic Article
|
Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804.
|
Academic Article
|
No Treatment Versus Partial Mastectomy Plus Radiation for Ductal Carcinoma In Situ.
|
Academic Article
|
A multi-institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1-2N1 breast cancer.
|
Academic Article
|
Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement.
|
Academic Article
|
Eliminating Breast Surgery for Invasive Cancer with Exceptional Response to Neoadjuvant Systemic Therapy: Prospective Multicenter Clinical Trial Planned Initial Feasibility Endpoint.
|
Academic Article
|
Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection.
|
Academic Article
|
Long-Term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal Involvement.
|
Academic Article
|
Premastectomy Radiotherapy and Immediate Breast Reconstruction: A Randomized Clinical Trial.
|